MAPT and tauopathy: Here we describe detection of the single (3 R or 4 R) and mixed (3 R/4 R) human tauopathies, and P301S transgenic mice using a mixture of purified full-length tau protein containing targeted cysteine to serine substitutions to allow greater sensitivity.